Qiran Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qiran Sun has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Fuyun Dong
Department of Obstetrics and Gynecology, Shanghai Fifth People′s Hospital, Fudan University, Shanghai, China, fudan.edu.cn
1 shared publication - Liwen Zhang
Department of Obstetrics and Gynecology, Shanghai Fifth People's Hospital, Fudan University, Shanghai, 200240, China; Center of Community-Based Health Research, Fudan University, Shanghai, 200240, China
1 shared publication - Ningning Hu
Department of Obstetrics and Gynecology, Shanghai Fifth People′s Hospital, Fudan University, Shanghai, China, fudan.edu.cn
1 shared publication - Rujun Chen
Department of Obstetrics and Gynecology, Shanghai Fifth People’s Hospital, Fudan University, China
1 shared publication - Weiyuan Xing
Department of Obstetrics and Gynecology, Shanghai Fifth People′s Hospital, Fudan University, Shanghai, China, fudan.edu.cn
1 shared publication - Xiaoqin Wang
Department of Obstetrics and Gynecology, Shanghai Fifth People′s Hospital, Fudan University, Shanghai, China, fudan.edu.cn
1 shared publication
Latest Publications
- Open Access
- 4 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1)
Unraveling the Causal Linkages of RBP7 and SCGB3A1 on Pelvic Organ Prolapse: Multifaceted Insights From Genome‐Wide Mendelian Randomization, Single‐Cell RNA Analysis, and Network Pharmacology
Background: Pelvic organ prolapse (POP) is a common pelvic floor disorder in middle‐aged and elderly women. Its pathophysiology is complex, involving weakened pelvic floor muscles and connective tissues. There is a need to explore its underlying pathogenesis and develop effective treatments. Methods: We integrated single‐cell sequencing (scRNA‐seq) data analysis with Mendelian randomization (MR) analysis. scRNA‐seq data of vaginal mucosal tissue were obtained from individuals with and without pelvic organ prolapse (POP); we then performed dimensionality reduction and cell subset identification. MR was conducted using GWAS summary statistics and eQTL data, following STROBE‐MR guidelines. We also performed protein‐protein interaction analysis, functional enrichment analysis, drug prediction, and molecular docking. Results: We identified RBP7 as a POP risk factor and SCGB3A1 as a protective factor. RBP7 high expression increased POP risk (IVW, OR 1.262, 95% CI 1.093–1.459, p = 0.002), whereas SCGB3A1 high expression decreased it (IVW, OR 0.907, 95% CI 0.844–0.975, p = 0.008). We found associated key genes and their biological processes and signaling pathways. We also predicted potential drugs and their binding affinities. Conclusion: The study highlights the significance of fibroblast gene expression changes in collagen metabolism for POP. It identified risk and protective genes and explored potential drugs. Future research should verify SCGB3A1 functions in fibroblasts, conduct preclinical drug trials, and clarify POP molecular mechanisms.
- 4 January 2026
- Published by Wiley in BioMed Research International
- Vol. 2026 (1)
Open AccessUnraveling the Causal Linkages of RBP7 and SCGB3A1 on Pelvic Organ Prolapse: Multifaceted Insights From Genome‐Wide Mendelian Randomization, Single‐Cell RNA Analysis, and Network Pharmacology
Background: Pelvic organ prolapse (POP) is a common pelvic floor disorder in middle‐aged and elderly women. Its pathophysiology is complex, involving weakened pelvic floor muscles and connective tissues. There is a need to explore its underlying pathogenesis and develop effective treatments. Methods: We integrated single‐cell sequencing (scRNA‐seq) data analysis with Mendelian randomization (MR) analysis. scRNA‐seq data of vaginal mucosal tissue were obtained from individuals with and without pelvic organ prolapse (POP); we then performed dimensionality reduction and cell subset identification. MR was conducted using GWAS summary statistics and eQTL data, following STROBE‐MR guidelines. We also performed protein‐protein interaction analysis, functional enrichment analysis, drug prediction, and molecular docking. Results: We identified RBP7 as a POP risk factor and SCGB3A1 as a protective factor. RBP7 high expression increased POP risk (IVW, OR 1.262, 95% CI 1.093–1.459, p = 0.002), whereas SCGB3A1 high expression decreased it (IVW, OR 0.907, 95% CI 0.844–0.975, p = 0.008). We found associated key genes and their biological processes and signaling pathways. We also predicted potential drugs and their binding affinities. Conclusion: The study highlights the significance of fibroblast gene expression changes in collagen metabolism for POP. It identified risk and protective genes and explored potential drugs. Future research should verify SCGB3A1 functions in fibroblasts, conduct preclinical drug trials, and clarify POP molecular mechanisms.